Table 2 Response rates to chronic hepatitis B treatments [17–20]
24th week | TDF | ETV | 3TC | LAM | LdT | TDF | ETV | 3TC | LAM | LdT |
|---|---|---|---|---|---|---|---|---|---|---|
<300 | 84.8 | 84.8 | 73.0 | 71.0 | 80.0 | 48.9 | 37.0 | 34.0 | 32.0 | 45.0 |
300–104 | 9.7 | 9.7 | 15.0 | 20.0 | 15.0 | 32.5 | 40.0 | 26.0 | 31.0 | 31.0 |
104–105 | 2.7 | 2.7 | 3.6 | 2.7 | 1.5 | 8.9 | 11.0 | 12.0 | 11.1 | 7.2 |
105–106 | 0.2 | 0.2 | 1.5 | 1.1 | 0.6 | 0.8 | 1.0 | 5.0 | 4.6 | 3.0 |
>106 | 2.7 | 2.7 | 6.9 | 5.2 | 2.9 | 8.9 | 11.0 | 23.0 | 21.3 | 13.8 |
48th week | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
<300 | 93.2 | 93.3 | 75.6 | 71.4 | 88.3 | 76.1 | 69.1 | 39.8 | 40.4 | 60.0 |
300–104 | 4.2 | 4.1 | 12.5 | 18.4 | 8.0 | 19.1 | 24.7 | 18.2 | 28.1 | 21.5 |
104–105 | 1.6 | 1.6 | 5.1 | 7.5 | 3.3 | 3.4 | 4.4 | 11.7 | 18.1 | 13.8 |
105–106 | 0.3 | 0.3 | 2.0 | 0.8 | 0.1 | 0.5 | 0.6 | 9.3 | 4.1 | 1.4 |
>106 | 0.6 | 0.6 | 4.8 | 1.9 | 0.3 | 0.9 | 1.2 | 21.0 | 9.3 | 3.3 |